Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Up 2,437.2% in August

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the recipient of a large increase in short interest during the month of August. As of August 14th, there was short interest totaling 88,674 shares, an increase of 2,437.2% from the July 30th total of 3,495 shares. Currently, 3.9% of the shares of the company are short sold. Based on an average daily volume of 307,856 shares, the days-to-cover ratio is presently 0.3 days.

Arcadia Biosciences Stock Performance

Shares of RKDA stock opened at $0.49 on Wednesday. Arcadia Biosciences has a 1 year low of $0.38 and a 1 year high of $6.71. The stock has a fifty day moving average of $0.65 and a two-hundred day moving average of $1.12. The firm has a market capitalization of $1.18 million, a PE ratio of -0.11 and a beta of 0.56.

Arcadia Biosciences (NASDAQ:RKDA) last released its quarterly earnings results on Thursday, August 13th. The basic materials company reported ($2.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.56) by ($1.53). The business had revenue of $1.44 million during the quarter, compared to the consensus estimate of $1.90 million. Arcadia Biosciences had a negative return on equity of 183.50% and a negative net margin of 234.53%.

Analysts Set New Price Targets

Separately, Weiss Ratings cut shares of Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 25th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision?breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.